CORRECTION article

Front. Pharmacol., 07 March 2024

Sec. Respiratory Pharmacology

Volume 15 - 2024 | https://doi.org/10.3389/fphar.2024.1365790

Corrigendum: Unravelling the therapeutic potential of botanicals against chronic obstructive pulmonary disease (COPD): molecular insights and future perspectives

  • 1. Department of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, India

  • 2. CytoGene Research & Development LLP, Lucknow, Uttar Pradesh, India

  • 3. Department of Life Sciences, Presidency University, Kolkata, India

  • 4. Human Molecular Cytogenetics and Stem Cell Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore, India

  • 5. Department of Pharmacology, Chitkara College of Pharmacy, Chitkara University, Chandigarh, India

  • 6. Chemical and Biochemical Processing Division, ICAR-Central Institute for Research on Cotton Technology, Mumbai, India

  • 7. School of Biological and Environmental Sciences, Shoolini University of Biotechnology and Management Sciences, Solan, India

  • 8. Department of Plant Biology and Biotechnology, Kanchi Mamunivar Government Institute for Postgraduate Studies and Research, Puducherry, India

  • 9. Department of Plant Biology, Institute of Environmental Biology, Wrocław University of Environmental and Life Sciences, Wrocław, Poland

In the published article, there was an error in the Affiliation information about Uttpal Anand [2]. Instead of “Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel,” it should be “CytoGene Research & Development LLP, Lucknow, Uttar Pradesh, India.”

As a result of the change in affiliation above, the Conflict of Interest statement must be amended to the following.

Statements

Conflict of interest

Author UA was employed by the company CytoGene Research & Development LLP.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way.

The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

lungs, inflammation, alternative therapy, medicinal plants, COVID-19, COPD, clinical efficacy, plant-based formulation

Citation

Mitra S, Anand U, Ghorai M, Vellingiri B, Jha NK, Behl T, Kumar M, Radha, Shekhawat MS, Proćków J and Dey A (2024) Corrigendum: Unravelling the therapeutic potential of botanicals against chronic obstructive pulmonary disease (COPD): molecular insights and future perspectives. Front. Pharmacol. 15:1365790. doi: 10.3389/fphar.2024.1365790

Received

05 January 2024

Accepted

20 February 2024

Published

07 March 2024

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

15 - 2024

Updates

Copyright

*Correspondence: Jarosław Proćków, ; Abhijit Dey,

† These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics